Drug affordability –potential tool for comparing illicit drug markets

The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has been collecting retail price data for a number of drug types alongside drug-specific purity information for over 15 years. While these data are useful for a number of monitoring and analytical purposes, they are not without their limitations and there are circumstances where additional adjustment needs to be considered.

Source: International Journal of Drug Policy - February 17, 2018 Category: Addiction Authors: Teodora Groshkova, Andrew Cunningham, Luis Royuela, Nicola Singleton, Tony Saggers, Roumen Sedefov Source Type: research